Cinnamon Attenuated Long-Term IGT-Induced Retinal Abnormalities via Regulation of Glucose Homeostasis in Neonatal Streptozotocin Induced Rat Model

  • Sivakesava Rao Kommula
  • Sai Santhosh Vadakattu
  • Srinivas Myadara
  • Uday Kumar Putcha
  • Raghava Rao Tamanam
  • Suryanarayana PallaEmail author
Original Research Article


Diabetic retinopathy (DR) is one of the major causes of blindness all over the world. According to the previous studies, impaired glucose tolerance (IGT) has been linked to retinal dysfunction/vascular damage. Decreased retinal function is an initial event of early DR. Although the biochemical and molecular events are not fully understood, glial activation, angiogenesis and oxidative stress are some of the pathways associated with early retinal abnormalities. Since IGT is associated with development of retinal dysfunction/vascular damage; as a preventive strategy, we have studied beneficial effect of Cinnamon as a hypoglycaemic agent on long-term IGT induced retinal abnormalities using neonatal streptozotocin (nSTZ) rat model. Control, IGT rats were maintained on AIN-93M diet alone and another set of IGT rats were maintained on AIN-93M diet with 3% Cinnamon for 8 months. At the end of the study, untreated IGT rats developed retinal functional abnormalities as assessed by electroretinogram (ERG) and the retinal structure did not alter as assessed by H&E staining. Further, increase in expressions of GFAP, VEGF and decreased expression of rhodopsin in untreated IGT rat retinas. 4-HNE, a marker of oxidative stress was also elevated in IGT state. Supplementation of Cinnamon to IGT rats had lowered fasting and postprandial glucose levels and also prevented retinal functional abnormalities. Further, Cinnamon protected photoreceptor cell damage, suppressed glial activation, angiogenesis and oxidative stress as there was an improved rhodopsin expression, inhibited elevated expressions of GFAP, VEGF and 4-HNE respectively. In conclusion, Cinnamon attenuated IGT induced retinal abnormalities probably through its hypoglycemic property.


Cinnamon Impaired glucose tolerance Retinal abnormalities Neonatal streptozotocin 



This work was supported by the Department of Biotechnology, Government of India (Grant No: BT/PR3446/BRB/10/969/2011) and National Institute of Nutrition (Indian Council of Medical research, Government of India) through intramural funding (#12-BS11).

Compliance with Ethical Standards

Conflict of interest

All authors declare no conflict of interest.

Ethical Approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.


  1. 1.
    Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA. 2007;298(8):902–16. Scholar
  2. 2.
    Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol Scand. 1996;74(6):523–7. Scholar
  3. 3.
    Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867–73. Scholar
  4. 4.
    Wong TY, Barr EL, Tapp RJ, Harper CA, Taylor HR, Zimmet PZ, et al. Retinopathy in persons with impaired glucose metabolism: the Australian diabetes obesity and lifestyle (AusDiab) study. Am J Ophthalmol. 2005;140:1157–9. Scholar
  5. 5.
    Wang J, Zhang RY, Chen RP, Sun J, Yang R, Ke XY, et al. Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Publ Health. 2013;13:633–9. Scholar
  6. 6.
    Liu Y, Yang J, Tao L, Lv H, Jiang X, Zhang M, et al. Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China. BMJ Open. 2017;7(9):e016280. Scholar
  7. 7.
    Karadeniz S, Kir N, Yilmaz MT, Ongör E, Dinççag N, Başar D, et al. Alteration of visual function in impaired glucose tolerance. Eur J Ophthalmol. 1996;6(1):59–62.CrossRefGoogle Scholar
  8. 8.
    Kern TS. Do photoreceptor cells cause the development of retinal vascular disease? Vision Res. 2017;139:65–71. Scholar
  9. 9.
    Bravo-Nuevo A, Walsh N, Stone J. Photoreceptor degeneration and loss of retinal function in the C57BL/6-C2J mouse. Invest Ophthalmol Vis Sci. 2004;45(6):2005–12.CrossRefGoogle Scholar
  10. 10.
    Reddy GB, Vasireddy V, Mandal MN, Tiruvalluru M, Wang XF, Jablonski MM, et al. A novel rat model with obesity-associated retinal degeneration. Invest Ophthalmol Vis Sci. 2009;50:3456–63. Scholar
  11. 11.
    Godisela KK, Reddy SS, Kumar CU, Saravanan N, Reddy PY, Jablonski MM, et al. Impact of obesity with impaired glucose tolerance on retinal degeneration in a rat model of metabolic syndrome. Mol Vis. 2017;23:263–74.Google Scholar
  12. 12.
    Li Q, Zemel E, Miller B, Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res. 2002;74:615–25. Scholar
  13. 13.
    Reisenhofer M, Pannicke T, Reichenbach A, Enzmann V. Characteristics of Müller glial cells in MNU-induced retinal degeneration. Vis Neurosci. 2016;33:e013. Scholar
  14. 14.
    Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008;27(4):331–71. Scholar
  15. 15.
    Militante J, Lombardini JB. Age-related retinal degeneration in animal models of aging: possible involvement of taurine deficiency and oxidative stress. Neurochem Res. 2004;29(1):151–60.CrossRefGoogle Scholar
  16. 16.
    Beidokhti MN, Jäger AK. Review of antidiabetic fruits, vegetables, beverages, oils and spices commonly consumed in the diet. J Ethnopharmacol. 2017;201:26–41. Scholar
  17. 17.
    Sahib AS. Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: a randomized, placebo-controlled clinical trial. J Intercult Ethnopharmacol. 2016;5(2):108–13. Scholar
  18. 18.
    Zare R, Nadjarzadeh A, Zarshenas MM, Shams M, Heydari M. Efficacy of cinnamon in patients with type II diabetes mellitus: a randomized controlled clinical trial. Clin Nutr. 2018;S0261–5614(18):30114–26. Scholar
  19. 19.
    Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr. 2007;85:1552–6. Scholar
  20. 20.
    Medagama AB. The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J. 2015;14:108–20. Scholar
  21. 21.
    Muthenna P, Akileshwari C, Saraswat M, Bhanuprakash Reddy G. Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br J Nutr. 2013;107(7):941–9. Scholar
  22. 22.
    Patil MA, Suryanarayana P, Putcha UK, Srinivas M, Reddy GB. Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract. Oxid Med Cell Longev. 2014. Scholar
  23. 23.
    Machida S, Kondo M, Jamison JA, Khan NW, Kononen LT, Sugawara T, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci. 2000;41(10):3200–9.Google Scholar
  24. 24.
    Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2001;50(6):537–46.Google Scholar
  25. 25.
    Arulmozhi DK, Veeranjaneyulu A, Bodhankar SL. Neonatal streptozotocin-induced rat model of Type 2 diabetes mellitus: a glance. Indian J Pharmacol. 2004;36(4):217–21.Google Scholar
  26. 26.
    Solomon TP, Blannin AK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol. 2009;105:969–76. Scholar
  27. 27.
    Frishman LA, Wang MH. Electroretinogram of human, monkey and mouse. Adler’s Physiol Eye. 2011;24:480–501.CrossRefGoogle Scholar
  28. 28.
    Miller RF, Dowling JE. Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram. J Neurophysiol. 1970;33:323–41. Scholar
  29. 29.
    Kern TS, Berkowitz BA. Photoreceptors in diabetic retinopathy. J Diabetes Investig. 2015;6(4):371–80. Scholar
  30. 30.
    Malechka VV, Moiseyev G, Takahashi Y, Shin Y, Ma JX. Impaired rhodopsin generation in the rat model of diabetic retinopathy. Am J Pathol. 2017;187(10):2222–31. Scholar
  31. 31.
    Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci. 2001;42(10):2408–13.Google Scholar
  32. 32.
    Salido EM, de Zavalía N, Schreier L, De Laurentiis A, Rettori V, Chianelli M, et al. Retinal changes in an experimental model of early type 2 diabetes in rats characterized by non-fasting hyperglycemia. Exp Neurol. 2012;236:151–60. Scholar

Copyright information

© Association of Clinical Biochemists of India 2019

Authors and Affiliations

  • Sivakesava Rao Kommula
    • 1
  • Sai Santhosh Vadakattu
    • 1
  • Srinivas Myadara
    • 2
  • Uday Kumar Putcha
    • 2
  • Raghava Rao Tamanam
    • 3
  • Suryanarayana Palla
    • 1
    Email author
  1. 1.Lipid Chemistry DivisionNational Institute of NutritionJamai-Osmania, HyderabadIndia
  2. 2.Pathology DivisionNational Institute of NutritionHyderabadIndia
  3. 3.Biochemistry DivisionAndhra UniversityVisakhapatnamIndia

Personalised recommendations